BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18551721)

  • 1. Maternal smoking during pregnancy and false positive maternal serum alpha-fetoprotein (MSAFP) screening for open neural tube defects.
    Urato AC; Quinn R; Pulkkinen A; Craigo SD; Allan W
    Prenat Diagn; 2008 Aug; 28(8):778-80. PubMed ID: 18551721
    [No Abstract]   [Full Text] [Related]  

  • 2. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated maternal serum alpha-fetoprotein values. How low is high?
    Lenke RR; Guerrieri J; Nemes JM; Kurczynski TW; French B; Gray M; Schut H; Ashwood ER
    J Reprod Med; 1989 Aug; 34(8):511-6. PubMed ID: 2478705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Fetoprotein screening.
    Burton BK
    Adv Pediatr; 1986; 33():181-96. PubMed ID: 2432763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
    Norem CT; Schoen EJ; Walton DL; Krieger RC; O'Keefe J; To TT; Ray GT
    Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.
    Jaques AM; Collins VR; Haynes K; Sheffield LJ; Francis I; Forbes R; Halliday JL
    J Med Screen; 2006; 13(1):8-13. PubMed ID: 16569299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent false-positives in AFP screening for open neural tube defects.
    Wald NJ; Huttly WJ; Rudnicka AR
    Prenat Diagn; 2004 Dec; 24(12):1018-9. PubMed ID: 15614882
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of folic acid fortification in the United States: markedly diminished high maternal serum alpha-fetoprotein values.
    Evans MI; Llurba E; Landsberger EJ; O'Brien JE; Harrison HH
    Obstet Gynecol; 2004 Mar; 103(3):474-9. PubMed ID: 14990409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal alpha fetoprotein screening.
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1053-4. PubMed ID: 6170380
    [No Abstract]   [Full Text] [Related]  

  • 11. Is MSAFP still a useful test for detecting open neural tube defects and ventral wall defects in the era of first-trimester and early second-trimester fetal anatomical ultrasounds?
    Roman AS; Gupta S; Fox NS; Saltzman D; Klauser CK; Rebarber A
    Fetal Diagn Ther; 2015; 37(3):206-10. PubMed ID: 25034077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum alpha-fetoprotein screening: report of a pilot project in Iowa.
    Williamson RA; Hanson JW; Grant SS
    Iowa Med; 1986 Feb; 76(2):61-2, 63-4. PubMed ID: 2420743
    [No Abstract]   [Full Text] [Related]  

  • 13. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

  • 14. Maternal serum alpha-fetoprotein screening.
    Reed BD; Ratcliffe S; Sayres W
    J Fam Pract; 1988 Jul; 27(1):20, 22, 26. PubMed ID: 2455763
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated maternal serum alpha-fetoprotein (MSAFP): interpretation and follow-up.
    Burton BK
    Clin Obstet Gynecol; 1988 Jun; 31(2):293-305. PubMed ID: 2456869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum alpha-fetoprotein screening program.
    Iowa Med; 1985 Jul; ():328, 330. PubMed ID: 2411678
    [No Abstract]   [Full Text] [Related]  

  • 17. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maternal alpha-fetoprotein. Its levels in the eluate of dried blood for screening antenatally defects in the closure of the neural tube (author's transl)].
    Travert G; Herlicoviez M
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(5):537-41. PubMed ID: 6161152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Open Neural Tube Defects.
    Krantz DA; Hallahan TW; Carmichael JB
    Clin Lab Med; 2016 Jun; 36(2):401-6. PubMed ID: 27235920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal alpha-fetoprotein screening.
    Br Med J (Clin Res Ed); 1981 Dec; 283(6306):1604-5. PubMed ID: 6171323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.